KOSDAQ - Delayed Quote KRW
Humedix Co., Ltd. (200670.KQ)
40,750.00
+700.00
+(1.75%)
At close: 3:30:30 PM GMT+9
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Jin-hwan Kim | Chief Executive Officer | -- | -- | 1965 |
Humedix Co., Ltd.
HuonsGlobal Building
6th Floor A-dong Pangyo I-Square 17, Changeop-ro, Sujeong-gu
Seongnam-si, 13449
South Korea
- Sector:
- Healthcare
- Industry: Drug Manufacturers - Specialty & Generic
Description
Humedix Co., Ltd. engages in the manufacture and sale of various pharmaceutical products in South Korea. The company offers prescription medicines, active pharmaceutical ingredients, medical devices, cosmetic, and health functional food products. It is also involved in manufacture and distribution of anticancer drugs. The company was formerly known as HVLS Co., Ltd. and changed its name to Humedix Co., Ltd. in 2010. Humedix Co., Ltd. was founded in 2002 and is headquartered in Seongnam-si, South Korea.
Corporate Governance
Humedix Co., Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 8, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
Humedix Co., Ltd. Earnings Date
Recent Events
March 28, 2025 at 12:00 AM UTC
Ex-Dividend Date